86 FR 183 pgs. 53116-53117 - Importer of Controlled Substances Application: Cardinal Health
Type: NOTICEVolume: 86Number: 183Pages: 53116 - 53117
Pages: 53116, 53117Docket number: [Docket No. DEA-895]
FR document: [FR Doc. 2021-20760 Filed 9-23-21; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-895]
Importer of Controlled Substances Application: Cardinal Health
AGENCY:
Drug Enforcement Administration, Justice.
ACTION:
Notice of application.
SUMMARY:
Cardinal Health has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
DATES:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before October 25, 2021. Such persons may also file a written request for a hearing on the application on or before October 25, 2021.
ADDRESSES:
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.34(a), this is notice that on July 22, 2021, Cardinal Health, 15 Ingram Boulevard, La Vergne, Tennessee 37086-3630, applied to be registered as an importer of the following basic class(es) of controlled substance(s):
| Controlled substance | Drug code | Schedule |
|---|---|---|
| Secobarbital | 2315 | II |
| Nabilone | 7379 | II |
The company plans to import the above controlled substance in finished dosage form for distribution to licensed registrants for the purpose of medical use only. No other activity for these drug codes is authorized for this registration.
[top] Approval of permit applications will occur only when the registrant's
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-20760 Filed 9-23-21; 8:45 am]
BILLING CODE P